X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Lori Reilly

Lori Reilly Lori M. Reilly is Executive Vice President for Policy, Research and Membership at the Pharmaceutical Research and Manufacturers of America (PhRMA). Ms. Reilly heads PhRMA’s policy and research department in the development and implementation of legislative, regulatory and political strategies to successfully navigate the ever-changing federal health care landscape, working to advance policies that encourage medical progress and patient access to the fruits of pharmaceutical innovation. In her membership role, Ms. Reilly leads the association’s efforts to grow the depth and breadth of innovative pharmaceutical company membership and engagement. Prior to joining PhRMA, Ms. Reilly was counsel at the U.S. House of Representatives Committee on Commerce as well as Chief of Staff/Counsel to Rep. Jon Christensen, a member of the House Ways and Means Committee. Ms. Reilly received a B.A. in Political Science from the University of Nebraska-Lincoln where she graduated with Honors, and a J.D. from the University of Nebraska College of Law.

Recent Posts

Event: New era of medicine comes to Capitol Hill

By Lori Reilly  |    April 30, 2019
Biopharmaceutical researchers work every day to translate science into new treatments and cures. This passion has led to breakthroughs like gene therapy to treat childhood blindness, ...   Read More

Putting 2014 Figures on Prescription Drug Spending in Context

By Lori Reilly  |    April 14, 2015
Last year was unique for our nation’s health care system. Nearly 10 million uninsured patients gained health insurance coverage – the largest gain in four decades -- and the FDA’s Center for Drug...   Read More

Which 340B Entities Are Getting Most of the Savings?

By Lori Reilly  |    March 19, 2015
When policymakers think about the 340B program, they often think of the thousands of clinics that depend on the 340B program to help underserved populations. The 340B program requires...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates